Detail akcie NanoVibronix Rg online

Business Summary: ENvue Medical, Inc. is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. Its segments include NanoVibronix, ENvue and Corporate. NanoVibronix is engaged in selling its products directly to patients as well as through distributor agreements. ENvue is engaged in selling its systems and Nasoenteral tubes and related services. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, ENvue Medical Inc revenues increased 6% to $2.2M. Net loss applicable to common stockholders increased 66% to $3.8M. Revenues reflect United States segment increase of 5% to $2.1M, New Zealand segment increase from $19K to $59K, Europe segment increase from $8K to $25K. Higher net loss reflects Biological device segment loss increase from $2.2M to $5.8M.